HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Possible mechanisms of resistance to cis-diamminedichloroplatinum (II) of human ovarian cancer cells.

Abstract
The mechanism of cis-diamminedichloroplatinum (II) (CDDP) resistance was examined by using a CDDP-resistant (KFr) cell line established by continuous exposure of KF cells (derived from serous cystadenocarcinoma of the ovary) to escalating doses of CDDP. When KFr cells were incubated with 66.7 microM CDDP, the uptake of CDDP was significantly inhibited and the cellular content in the KFr cells was about a half of that in KF cells after incubation for 4 h. When the KF or KFr cells were incubated for 4 h with 100 microM CDDP, the release pattern of CDDP from KFr cells was similar to that from KF cells. In addition, the DNA histogram of both KF and KFr cells revealed that KF cells seemed to contain two clones of cell population and the KFr cells may have been selected by exposure to CDDP. At 3 h after intraperitoneal administration of 0.5 mg of CDDP per mouse to nude mice with KF or KFr tumor, the CDDP content in the KFr tumor was significantly lower than that in the KF tumor. In contrast, at 6 or 9 h after CDDP administration the CDDP content in the KFr tumor was significantly higher than that in the KF tumor. Furthermore, the KFr cells had cross-resistance to various CDDP analogues including carboplatin. It was shown that cellular uptakes of two CDDP analogues into KFr cells were significantly lower than those into KF cells.
AuthorsY Kikuchi, I Iwano, M Miyauchi, T Kita, M Sugita, Y Tenjin, I Nagata
JournalJapanese journal of cancer research : Gann (Jpn J Cancer Res) 1990 Jun-Jul Vol. 81 Issue 6-7 Pg. 701-6 ISSN: 0910-5050 [Print] Japan
PMID2119370 (Publication Type: Journal Article)
Chemical References
  • DNA
  • Cisplatin
Topics
  • Animals
  • Cells, Cultured
  • Cisplatin (therapeutic use)
  • Cystadenocarcinoma (drug therapy)
  • DNA (analysis)
  • Dose-Response Relationship, Drug
  • Drug Resistance
  • Female
  • Flow Cytometry
  • Humans
  • In Vitro Techniques
  • Mice
  • Mice, Nude
  • Ovarian Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: